Publication: Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy (vol 43, 251, 2024)
Program
KU-Authors
Sezen, Duygu
KU Authors
Co-Authors
He, Kewen
Puebla-Osorio, Nahum
Barsoumian, Hampartsoum B.
Rafq, Zahid
Riad, Thomas S.
Hu, Yun
Huang, Ailing
Voss, Tifany A.
Leyton, Claudia S. Kettlun
Schuda, Lily Jae
Advisor
Publication Date
Language
Type
Journal Title
Journal ISSN
Volume Title
Abstract
Source:
Journal of Experimental and Clinical Cancer Research
Publisher:
BMC
Keywords:
Subject
Oncology